Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 4c ; Offers Guidance

Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $180.9 million versus the consensus estimate of $169 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2026 EPS of $0.90-$1.10, versus the consensus of $1.00.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• Medpace Holdings (MEDP) Tops Q2 EPS by 27c; offers guidance